82 FR 46511 - ``Partnering to Prevent Hypoglycemia'' Listening Session
DEPARTMENT OF HEALTH AND HUMAN SERVICES Federal Register Volume 82, Issue 192 (October 5, 2017)
Federal Register Volume 82, Issue 192 (October 5, 2017)
| Page Range | 46511-46512 | |
| FR Document | 2017-21503 |
[Federal Register Volume 82, Number 192 (Thursday, October 5, 2017)] [Notices] [Pages 46511-46512] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2017-21503] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES ``Partnering to Prevent Hypoglycemia'' Listening Session AGENCY: Office of Disease Prevention and Health Promotion, Office of the Secretary, U.S. Department of Health and Human Services. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Office of Disease Prevention and Health Promotion (ODPHP) is hosting a listening session titled, ``Partnering to Prevent Hypoglycemia.'' The purpose of this [[Page 46512]] listening session is to exchange information about the public health importance of hypoglycemia, and discuss federal efforts to reduce preventable hypoglycemia from diabetes medications. The Department of Health and Human Services invites public and private professionals, organizations, and consumer representatives to register to attend this listening session at https://health.gov/news/. DATES: The public listening session will be held on November 1, 2017, from 9:00 a.m. to 4:00 p.m. EDT. ADDRESSES: The meeting will only be accessible by attendance in-person. For in-person participants, the meeting will take place in the Hubert H. Humphrey Building, Room 800, 200 Independence Ave. SW., Washington, DC 20201. FOR FURTHER INFORMATION CONTACT: Ndome Essoka, Health Policy Fellow, Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, 1101 Wootton Parkway, Suite LL100, Rockville, MD 20852, phone: 240-453-8217, email: [email protected] or [email protected] (please indicate in the subject line: Partnering to Prevent Hypoglycemia). SUPPLEMENTARY INFORMATION: In September 2012, in response to heightened awareness of the contribution of adverse drug events (ADEs) to the burden of health care-related harm and costs, the Office of the Assistant Secretary for Health (OASH) marshaled the wide-ranging and diverse resources of federal partners to form an extensive interagency partnership, the Federal Interagency Steering Committee and Workgroups for Adverse Drug Events, whose goals would be to develop the ADE Action Plan, as well as identify measures to track national progress in reducing ADEs and targets to meet based on those measures. ODPHP, in conjunction with the Federal Interagency Steering Committee and three Federal Interagency Workgroups, developed and released the final ADE Action Plan in 2014. The ADE Action Plan seeks to engage all stakeholders in coordinated efforts to reduce ADEs that are not only clinically significant but largely preventable. Inpatient and outpatient use of anticoagulants, diabetes agents, and opioid analgesics (with specific focus on ADEs from therapeutic use of opioids) contribute to the reason why ADEs account for the greatest number of measurable harms. The ADE Action Plan identifies the federal government's highest priority strategies and opportunities for advancement, which will have the greatest impact on reducing ADEs. Implementation of these strategies is expected to result in safer and higher quality health care services, reduced health care costs, informed and engaged consumers and, ultimately, improved health outcomes. For more information on the ADE Action Plan, visit https://health.gov/hcq/ade-action-plan.asp. Purpose of the Meeting: ODPHP is hosting a listening session titled, ``Reducing Preventable Hypoglycemia.'' The purpose of this listening session is to exchange information about the public health importance of hypoglycemia, and discuss federal efforts to reduce preventable hypoglycemia from diabetes medications. This information may assist ODPHP and federal partners in identifying how patients and providers are affected by hypoglycemia, where gaps in knowledge exist, and how information can be better disseminated. Meeting Registration: There is no registration fee to attend the public listening session. Early registration is recommended because seating is limited, and registration will be on a first-come, first- served basis. There will be no onsite registration. Persons interested in attending this listening session must register online at https://health.gov/news/. For those without Internet access, please contact Ndome Essoka (see FOR FURTHER INFORMATION CONTACT) to register. If you need special accommodations due to a disability, please contact Ndome Essoka at least seven days in advance. Dated: September 29, 2017. Don Wright, Deputy Assistant Secretary for Health (Disease Prevention and Health Promotion). [FR Doc. 2017-21503 Filed 10-4-17; 8:45 am] BILLING CODE 4150-32-P
![Federal Register / Vol. 82, No. 192 / Thursday, October 5, 2017 / Notices 46511
DEPARTMENT OF HEALTH AND SUPPLEMENTARY INFORMATION: When dates. In response to a Federal Register
HUMAN SERVICES submitting comments or requesting notice announcing the FTCA Program
information, please include the deeming applications for Free Clinics
Health Resources and Services information request collection title for published on June 23, 2017 (Vol. 82, No.
Administration reference, in compliance with Section 120, pages 28667–28668), BPHC
3506(c)(2)(A) of the Paperwork received several comments requesting
Agency Information Collection Reduction Act of 1995. that FTCA eligibility be extended to free
Activities: Submission to OMB for Information Collection Request Title: clinics as entities. In response, BPHC
Review and Approval; Public Comment Federal Tort Claims Act (FTCA) notes that per Section 224(o) of the PHS
Request; Information Collection Program Deeming Applications for Free Act (42 U.S.C. 233(o)), FTCA coverage
Request Title: Federal Tort Claims Act Clinics—OMB No. 0915–0293— cannot be extended to the free clinic as
(FTCA) Program Deeming Applications Extension. an entity. Rather, coverage is only
for Free Clinics [OMB No. 0915–0293— Abstract: Section 224(o) of the Public available to eligible and approved free
Extension] Health Service (PHS) Act (42 U.S.C. clinic-sponsored individuals. BPHC
AGENCY: Health Resources and Services 233(o)), as amended, authorizes the notes that the estimated number of
Administration (HRSA), Department of ‘‘deeming’’ of certain individuals as responses per respondent has increased
Health and Human Services. PHS employees for the purposes of from one to three annually due to
receiving Federal Tort Claims Act sponsoring free clinics submitting a
ACTION: Notice.
(FTCA) coverage. Section 224(o) relates greater number of supplemental
SUMMARY: In compliance with the to employees, officers, and contractors applications on behalf of individuals
Paperwork Reduction Act of 1995, at qualifying free clinics. The Free who on-board throughout a calendar
HRSA has submitted an Information Clinics FTCA Program is administered year.
Collection Request (ICR) to the Office of by HRSA’s Bureau of Primary Health Likely Respondents: Respondents
Management and Budget (OMB) for Care (BPHC). Sponsoring free clinics are include free clinics seeking deemed
review and approval. Comments required by law to submit deeming PHS employee status on behalf of their
submitted during the first public review applications in the specified form and sponsored individuals for purposes of
of this ICR will be provided to OMB. manner on behalf of named individuals FTCA coverage.
OMB will accept further comments from for review and approval, resulting in a Burden Statement: Burden in this
the public during the review and ‘‘deeming determination’’ that includes context means the time expended by
approval period. associated FTCA coverage for these persons to generate, maintain, retain,
DATES: Comments on this ICR must be
individuals. disclose, or provide the information
received no later than November 6, Need and Proposed Use of the requested. This includes the time
2017. Information: Deeming applications must needed to review instructions; to
address certain specified criteria develop, acquire, install, and utilize
ADDRESSES: Submit your comments, required by law for deeming technology and systems for the purpose
including the Information Collection determinations to be issued, and FTCA of collecting, validating, and verifying
Request Title, to the desk officer for application forms are critical to BPHC’s information, processing and
HRSA, either by email to OIRA_ deeming determination processes. These maintaining information, and disclosing
submission@omb.eop.gov or by fax to forms provide BPHC with the and providing information; to train
202–395–5806. information necessary to evaluate an personnel and to be able to respond to
FOR FURTHER INFORMATION CONTACT: To application and determine whether an a collection of information; to search
request a copy of the clearance requests individual meets the requirements for data sources; to complete and review
submitted to OMB for review, email Lisa deemed PHS employee status for the the collection of information; and to
Wright-Solomon, the HRSA Information purposes of FTCA coverage. FTCA transmit or otherwise disclose the
Collection Clearance Officer at application forms for free clinics do not information. The total annual burden
paperwork@hrsa.gov or call (301) 443– require any changes with this extension hours estimated for this ICR are
1984. other than to update the applicable summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Average
Number of
Number of Total burden per Total burden
Form name responses per
respondents responses response hours
respondent (in hours)
FTCA Program Deeming Application for Free Clinics ......... 228 3 684 2 1,368
Total .............................................................................. 228 3 684 2 1,368
Amy McNulty, DEPARTMENT OF HEALTH AND Secretary, U.S. Department of Health
Acting Director, Division of the Executive HUMAN SERVICES and Human Services.
ethrower on DSK3G9T082PROD with NOTICES
Secretariat. ACTION: Notice.
[FR Doc. 2017–21488 Filed 10–4–17; 8:45 am] ‘‘Partnering to Prevent Hypoglycemia’’
BILLING CODE 4165–15–P Listening Session SUMMARY: The Office of Disease
Prevention and Health Promotion
AGENCY: Office of Disease Prevention (ODPHP) is hosting a listening session
and Health Promotion, Office of the titled, ‘‘Partnering to Prevent
Hypoglycemia.’’ The purpose of this
VerDate Sep<11>2014 19:52 Oct 04, 2017 Jkt 244001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\05OCN1.SGM 05OCN1](https://thefederalregister.org/doc/82_FR_46703/page/1.svg)
![46512 Federal Register / Vol. 82, No. 192 / Thursday, October 5, 2017 / Notices
listening session is to exchange will have the greatest impact on October meeting, the Advisory Council
information about the public health reducing ADEs. Implementation of these will welcome its new members and
importance of hypoglycemia, and strategies is expected to result in safer invite them to share their experiences
discuss federal efforts to reduce and higher quality health care services, and where they see the Council going
preventable hypoglycemia from diabetes reduced health care costs, informed and over the length of their terms. The
medications. The Department of Health engaged consumers and, ultimately, Advisory Council will also spend some
and Human Services invites public and improved health outcomes. For more time discussing the process of
private professionals, organizations, and information on the ADE Action Plan, developing recommendations and how
consumer representatives to register to visit https://health.gov/hcq/ade-action- those recommendations relate to the
attend this listening session at https:// plan.asp. National Plan. The Council will then
health.gov/news/. Purpose of the Meeting: ODPHP is spend much of the meeting discussing
DATES: The public listening session will hosting a listening session titled, the National Research Summit on Care,
be held on November 1, 2017, from 9:00 ‘‘Reducing Preventable Hypoglycemia.’’ Services, and Supports for Persons with
a.m. to 4:00 p.m. EDT. The purpose of this listening session is Dementia and Their Caregivers, held on
ADDRESSES: The meeting will only be to exchange information about the October 16–17.
accessible by attendance in-person. For public health importance of DATES: The meeting will be held on
in-person participants, the meeting will hypoglycemia, and discuss federal October 27, 2017 from 9:00 a.m. to 5:00
take place in the Hubert H. Humphrey efforts to reduce preventable p.m. EDT.
Building, Room 800, 200 Independence hypoglycemia from diabetes ADDRESSES: The meeting will be held in
Ave. SW., Washington, DC 20201. medications. This information may Room 800 in the Hubert H. Humphrey
FOR FURTHER INFORMATION CONTACT: assist ODPHP and federal partners in Building, 200 Independence Avenue
Ndome Essoka, Health Policy Fellow, identifying how patients and providers SW., Washington, DC 20201.
Office of Disease Prevention and Health are affected by hypoglycemia, where Comments: Time is allocated in the
Promotion, Office of the Assistant gaps in knowledge exist, and how afternoon on the agenda to hear public
Secretary for Health, U.S. Department of information can be better disseminated. comments. The time for oral comments
Health and Human Services, 1101 Meeting Registration: There is no will be limited to two (2) minutes per
Wootton Parkway, Suite LL100, registration fee to attend the public individual. In lieu of oral comments,
Rockville, MD 20852, phone: 240–453– listening session. Early registration is formal written comments may be
8217, email: ndome.essoka@hhs.gov or recommended because seating is submitted for the record to Rohini
OHQ@hhs.gov (please indicate in the limited, and registration will be on a Khillan, OASPE, 200 Independence
subject line: Partnering to Prevent first-come, first-served basis. There will Avenue SW., Room 424E, Washington,
Hypoglycemia). be no onsite registration. Persons DC 20201. Comments may also be sent
interested in attending this listening to napa@hhs.gov. Those submitting
SUPPLEMENTARY INFORMATION: In
session must register online at https:// written comments should identify
September 2012, in response to health.gov/news/. For those without
heightened awareness of the themselves and any relevant
Internet access, please contact Ndome organizational affiliations.
contribution of adverse drug events Essoka (see FOR FURTHER INFORMATION
(ADEs) to the burden of health care- FOR FURTHER INFORMATION CONTACT:
CONTACT) to register. If you need special Rohini Khillan (202) 690–5932,
related harm and costs, the Office of the
accommodations due to a disability, rohini.khillan@hhs.gov. Note: Seating
Assistant Secretary for Health (OASH)
please contact Ndome Essoka at least may be limited. Those wishing to attend
marshaled the wide-ranging and diverse
seven days in advance. the meeting must send an email to
resources of federal partners to form an
extensive interagency partnership, the Dated: September 29, 2017. napa@hhs.gov and put ‘‘October 27
Federal Interagency Steering Committee Don Wright, Meeting Attendance’’ in the Subject line
and Workgroups for Adverse Drug Deputy Assistant Secretary for Health by Tuesday, October 17, so that their
Events, whose goals would be to (Disease Prevention and Health Promotion). names may be put on a list of expected
develop the ADE Action Plan, as well as [FR Doc. 2017–21503 Filed 10–4–17; 8:45 am] attendees and forwarded to the security
identify measures to track national BILLING CODE 4150–32–P officers at the Department of Health and
progress in reducing ADEs and targets to Human Services. Any interested
meet based on those measures. member of the public who is a non-U.S.
ODPHP, in conjunction with the DEPARTMENT OF HEALTH AND citizen should include this information
Federal Interagency Steering Committee HUMAN SERVICES at the time of registration to ensure that
and three Federal Interagency the appropriate security procedure to
Workgroups, developed and released Advisory Council on Alzheimer’s gain entry to the building is carried out.
the final ADE Action Plan in 2014. The Research, Care, and Services; Meeting Although the meeting is open to the
ADE Action Plan seeks to engage all AGENCY: Assistant Secretary for public, procedures governing security
stakeholders in coordinated efforts to Planning and Evaluation, HHS. and the entrance to Federal buildings
reduce ADEs that are not only clinically ACTION: Notice of meeting.
may change without notice. If you wish
significant but largely preventable. to make a public comment, you must
Inpatient and outpatient use of SUMMARY: This notice announces the note that within your email.
anticoagulants, diabetes agents, and public meeting of the Advisory Council SUPPLEMENTARY INFORMATION: Notice of
opioid analgesics (with specific focus on on Alzheimer’s Research, Care, and these meetings is given under the
ethrower on DSK3G9T082PROD with NOTICES
ADEs from therapeutic use of opioids) Services (Advisory Council). The Federal Advisory Committee Act (5
contribute to the reason why ADEs Advisory Council on Alzheimer’s U.S.C. App. 2, section 10(a)(1) and
account for the greatest number of Research, Care, and Services provides (a)(2)).
measurable harms. The ADE Action advice on how to prevent or reduce the Topics of the Meeting: During the
Plan identifies the federal government’s burden of Alzheimer’s disease and October meeting, the Advisory Council
highest priority strategies and related dementias on people with the will welcome its new members and
opportunities for advancement, which disease and their caregivers. During the invite them to share their experiences
VerDate Sep<11>2014 19:52 Oct 04, 2017 Jkt 244001 PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 E:\FR\FM\05OCN1.SGM 05OCN1](https://thefederalregister.org/doc/82_FR_46703/page/2.svg)
Document Created: 2017-10-05 00:53:37
Document Modified: 2017-10-05 00:53:37
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice. | |
| Dates | The public listening session will be held on November 1, 2017, from 9:00 a.m. to 4:00 p.m. EDT. | |
| Contact | Ndome Essoka, Health Policy Fellow, Office of Disease Prevention and Health Promotion, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, 1101 Wootton Parkway, Suite LL100, Rockville, MD 20852, phone: 240-453-8217, email: [email protected] or [email protected] (please indicate in the subject line: Partnering to Prevent Hypoglycemia). | |
| FR Citation | 82 FR 46511 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR